Praxis Precision price target lowered to $85 from $150 at Needham

TipRanks

Tue, Mar 4, 2025, 6:05 AM 1 min read

Needham lowered the firm’s price target on Praxis Precision (PRAX) to $85 from $150 and keeps a Buy rating on the shares. The firm is removing Ulixa sales from its model after the company disclosed last week that Independent Data Monitoring Committee recommended that its study be stopped for futility, due to the results being unlikely to meet the primary efficacy endpoint, the analyst tells investors in a research note. At this time, the firm is assuming that the probability of success for this program is “minimal” until there is more clarity on the final topline, Needham added.

Discover the Best Stocks and Maximize Your Portfolio:

See what stocks are receiving Strong Buy ratings from top-rated analysts.
Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on PRAX: